FDA Approves Eli Lilly's Zyprexa;
A Drug that Treats Schizophrenia

INDIANAPOLIS -- Eli Lilly & Co. said the U.S. Food and Drug Administration approved its Zyprexa drug to treat schizophrenia, a brain disorder characterized by acute episodes of delusions, hallucinations and long-term impairments.

Zyprexa was tested in a 326-outpatient study that was terminated early after the drug's effectiveness was proved. The study's results showed placebo-treated patients were about 10 times as likely to...